Candelino Roberto 4

What Happened

• Roberto Candelino, a director of Scotts Miracle‑Gro Co. (SMG), received a grant of 68 derivative units on March 6, 2026. The filing lists the transaction as an award/acquisition (derivative); no per‑share price or total dollar value is provided. This appears to be a compensation award (DSUs/RSUs style) rather than an open‑market purchase or sale.

Key Details

• Transaction date: March 6, 2026. Filing date (Form 4): March 9, 2026 — filed within the SEC’s two‑business‑day window (timely).
• Amount: 68 derivative units (reported as "shares" of a derivative instrument); price listed as N/A; total value not disclosed.
• Shares owned after transaction: not specified in the Form 4.
• Footnote: Dividend equivalent rights accrued on DSU/RSU grants become exercisable proportionately with the underlying units; each dividend equivalent right is the economic equivalent of one common share.

Context

• This is a routine compensation award to a director (commonly deferred stock units or restricted stock units) and does not indicate an open‑market purchase or sale. The derivative units and associated dividend equivalents typically convert to common shares or cash under the grant’s terms at vesting or distribution.